COVID-19 Vaccines

被引:18
作者
Hahn, William O. [1 ]
Wiley, Zanthia [2 ]
机构
[1] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98195 USA
[2] Emory Univ, Dept Med, Div Infect Dis, Infect Dis Clin, 550 Peachtree St NE,7th Floor,Med Off Tower, Atlanta, GA 30308 USA
关键词
COVID-19; Janssen (Ad.26.CoV2); SARS-CoV-2; Vaccine; mRNA vaccine; vaccine efficacy trials; post-marketing vaccine surveillance; HOSPITALIZATION; SARS-COV-2; STATES;
D O I
10.1016/j.idc.2022.01.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:481 / 494
页数:14
相关论文
共 34 条
[31]  
Uschner D, 2021, MEDRXIV, V2021, DOI 10.10.21264812
[32]   Myocarditis after Covid-19 Vaccination in a Large Health Care Organization [J].
Witberg, Guy ;
Barda, Noam ;
Hoss, Sara ;
Richter, Ilan ;
Wiessman, Maya ;
Aviv, Yaron ;
Grinberg, Tzlil ;
Auster, Oren ;
Dagan, Noa ;
Balicer, Ran D. ;
Kornowski, Ran .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (23) :2132-2139
[33]   Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens [J].
Wolf, Jayanthi ;
Bruno, Samantha ;
Eichberg, Michael ;
Jannat, Risat ;
Rudo, Sharon ;
VanRheenen, Susan ;
Coller, Beth-Ann .
NPJ VACCINES, 2020, 5 (01)
[34]   Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021 [J].
Woo, Emily Jane ;
Mba-Jonas, Adamma ;
Dimova, Rositsa B. ;
Alimchandani, Meghna ;
Zinderman, Craig E. ;
Nair, Narayan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (16) :1606-1613